Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC

@article{Yang2008ClinicalAO,
  title={Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC},
  author={Po Yang and Minghui Liang and Ying-xian Zhang and Baozhong Shen},
  journal={Advances in Therapy},
  year={2008},
  volume={25},
  pages={787-794}
}
IntroductionHepatocellular carcinoma (HCC) is one of the most common cancer-related causes of death worldwide and there is a clear need for further treatment options. In this study, we assessed the efficacy of a combination of lentinan (a fungal extract), transcatheter arterial chemoembolisation (TACE) and radiofrequency ablation (RFA) in HCC patients.MethodsSeventy-eight patients with HCC confirmed by pathology and iconographical checks were used in this study. A total of 136 tumours with a… 

Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center

TLDR
Combination therapy with RFA and TACE for unresectable HCC, compared to TACE alone, may offer a survival benefit for a selected group of patients with HCC.

Transarterial Chemoembolization in Combination with Local Therapies for Hepatocellular Carcinoma: A Meta-Analysis

TLDR
It is demonstrated that TACE combined with local treatments, especially PEI, HIFU or 3D-CRT could improve the overall survival status than performing TACE alone.

Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis

TLDR
The combination of TACE with RFA can improve the overall survival rate and provides better prognosis for patients with HCC, but more randomized controlled trials using large sample sizes are needed to provide sufficient evidence.

Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis

TLDR
The combination of TACE with RFA can improve the overall survival rate and provides better prognosis for patients with HCC, but more randomized controlled trials using large sample size are needed to provide sufficient evidence.

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma

TLDR
Patients treated with SABR after incomplete TACE had similar survival outcomes to those achieving complete response to TACE or receiving curative treatments, however, patients receiving non-curative treatments had significantly lower survival rates than the other groups.

Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma

TLDR
High-quality evidence suggests that TACE plus RFA improve the survival rates compared with RFA alone for patients with HCC.

Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.

TLDR
The combination of RFA with TACE has advantages in improving overall survival rate, and provides better prognosis for patients with intermediate- and large-size HCC.

Comparison of Radiofrequency Ablation with or without Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials

TLDR
The curative effect and safety of compare radiofrequency ablation with or without transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma with the help of a meta-analysis of randomized controlled trials (RCTs) was evaluated.

Transarterial chemoembolization combined with radiofrequency ablation in the treatment of hepatocellular carcinomas larger than 5 cm

TLDR
The data of the study indicates that TACE combined with RFA in the treatment of HCC larger than 5 cm is an effective comprehensive interventional therapy.

Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis

TLDR
The combination of RFA with TACE can improve the overall survival rate and the recurrence-free survival rate for patients with HCC.
...

References

SHOWING 1-10 OF 20 REFERENCES

Combination of transcatheter arterial chemoembolization and CT-guided radiofrenquency ablation in treating advanced hepatocellular carcinoma

TLDR
The therapeutic effects of T ACE combined with CT-guided RFA show better results than that of TACE alone, and there were significant statistical differences between the two groups.

RFA combined with TACE and ethanol injection for unresectable hepatic carcinoma

TLDR
RFA combined with TACE and PEI is a safe, well-tolerated and effective method for unresectable hepatic carcinoma, and may improve the treatment efficacy of URLC.

Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours

TLDR
Hematic arterial chemoembolization with STZ is an effective treatment for patients with liver metastases caused by digestive endocrine tumours and effectively controlled hypoglycaemic attacks in the patient with insulinoma.

Management of hepatocellular carcinoma

Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model.

TLDR
RF ablation combined with TAE with iodized oil and gelatin sponge induces the greatest area of coagulation necrosis accompanied by peripherally spreading segmental necrosis in normal pig liver tissue.

The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas

TLDR
Systemic therapy for carcinoid tumors and islet cell carcinomas should be carried out in a research setting to restore the patient to a better general and nutritional status so that more aggressive and definitive therapy can be undertaken with an acceptable risk.

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults

This document, on the diagnosis and treatment of patients with hepatocellular carcinoma (HCC), was commissioned by the British Society of Gastroenterology as part of a wider initiative to develop

Cytoreductive hepatic surgery for neuroendocrine tumors.

TLDR
The experience suggests that curative surgery should be considered in all patients with completely resectable metastatic disease and that palliative surgery, despite the short duration of complete relief, should be considering in selected patients because it delays and may reduce the subsequent need for medical therapy.

Treatment of metastatic glucagonoma to the liver: case report and literature review.

TLDR
Based on the experience, glucagonoma with metachronous, multiple, diffuse and bilobar hepatic metastases should be treated with octreotide plus hepatic arterial chemoembolization with improved outcome and prognosis.